EV | |
---|---|
Molecular structure via molpic | |
Conformer structure via 3Dmol.js | |
Molecular formula | C23H32O3[1] |
Molecular mass | 356.5 g/mol[1] |
Predicted LogP | 6[1] |
Chirality | absolute[2] |
Identifiers [] | |
---|---|
IUPAC name | [(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] pentanoate[1] |
SMILES | CCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=C3C=CC(=C4)O)C[1] |
InChI | InChI=1S/C23H32O3/c1-3-4-5-22(25)26-21-11-10-20-19-8-6-15-14-16(24)7-9-17(15)18(19)12-13-23(20,21)2/h7,9,14,18-21,24H,3-6,8,10-13H2,1-2H3/t18-,19-,20+,21+,23+/m1/s1[1] |
InChIKey | RSEPBGGWRJCQGY-RBRWEJTLSA-N[1] |
Dosing | |
---|---|
Elimination half-life | Oral: 12 – 20 hours (as estradiol)Intramuscular injection injection: 3.5 (1.2 – 7.2) days |
Duration of action | Intramuscular injection injection:• 5 mg: 7 – 8 days• 10 mg: 10 – 14 days[3]• 40 mg: 2 – 3 weeks• 100 mg: 3 – 4 weeks |
Estradiol valerate
(Redirected from estradiol valerate)
Estradiol valerate (also known as Estradiol 17-valerate, Estradiol valerianate, Estraval, Neofollin, Femogex, Oestradiol valerate, Atladiol, Climaval, Deladiol or Duratrad)
Chemistry
Stereochemistry
Estradiol valerate is a absolute mixture:
Stereoisomers [] |
---|
Subjective effects
0xea / Estradiol valerate via Subcutaneous and Intramuscular | Prodrug Ester of Estradiol; Crashes when injected weekly |
Legal status
- United States: Estradiol valerate is a prescription only substance.
See also
External links
- Estradiol valerate (Wikipedia)
- Estradiol valerate (Wikidata)
- Estradiol valerate (DrugBank)
- Estradiol valerate (PubChem)
- Estradiol valerate (ChEMBL)
- Estradiol valerate (ChEBI)
- Estradiol valerate (Common Chemistry)
- Estradiol valerate (HMDB)
- Estradiol valerate (KEGG)
- Estradiol valerate (UNII)
- Estradiol valerate (EPA DSSTox)
References
National Center for Biotechnology Information. PubChem Compound Summary for CID 13791, Estradiol valerate. Accessed July 7, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/13791
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Estradiol valerate. UNII: OKG364O896. Global Substance Registration System. Accessed July 7, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/OKG364O896
Labhart A. Clinical Endocrinology: Theory and Practice. Springer Science & Business Media. December 6, 2012. Accessed July 7, 2025. https://books.google.com/books?id=DAgJCAAAQBAJ&pg=PA551